Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy Wedbush

Start price
€202.00
22.02.24 / 50%
Target price
€284.50
22.02.25
Performance (%)
20.64%
Price
€243.70
03.05.24
Summary
This prediction is currently active. The BUY prediction by Wedbush currently has a performance of 20.64%. This prediction currently runs until 22.02.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
United Therapeutics 10.773% 10.773%
iShares Core DAX® -0.922% -1.993%
iShares Nasdaq 100 0.371% -0.868%
iShares Nikkei 225® 2.224% -5.187%
iShares S&P 500 -0.026% -0.918%

Comments by Wedbush for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) 20.64%
Target price 284.500
Change
Ends at 22.02.25

United Therapeutics Co. (NASDAQ: UTHR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $308.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat

Stopped prediction by Wedbush for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€214.00
02.11.23
€289.92
02.11.24
13.88%
03.05.24